Evidence map›Paper›PMID 33306990›Full record

ArticleLancet (London, England)2021

Oxford-AstraZeneca COVID-19 vaccine efficacy.

Maria Deloria Knoll, Chizoba Wonodi

2 registry-linked trialsAbstract readComment
In one paragraph

Article in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 377 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
377citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04798677 nacompletednot on this map

Efficacy and Tolerability of a Nutritional Supplementation With ABBC-1, a Symbiotic Combination of Beta-glucans and Selenium and Zinc Enriched Probiotics, in Volunteers Receiving the Influenza or the Covid-19 Vaccines

TypeinterventionalSponsorAB BiotekRan2020 to 2021Enrolled72ConditionsImmunity, Vaccine Reaction, Influenza, Covid19ArmsABBC1 Immunoessential, Placebo
NCT05025514 terminatednot on this map

Pharmaco-epidemiological Study of COVID 19 Vaccines in Patients Undergoing Immunotherapy for Cancer. A Retrospective Open Cohort Study.

TypeobservationalSponsorCentre Hospitalier Universitaire de NīmesRan2021 to 2022Enrolled125ConditionsCancer, Immunotherapy
3 · Its place in the literature

Who cites it

377 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. The Role of Digital Technology in Curbing COVID-19.International journal of environmental research and public health · 2022
    Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

317 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Maria Deloria KnollJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21231 USA. Electronic address: mknoll2@jhu.edu.
Chizoba WonodiJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21231 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Viral VaccinesBrazilChAdOx1 nCoV-19COVID-19 VaccinesHumansSARS-CoV-2South AfricaUnited KingdomChAdOx1 nCoV-19COVID-19 VaccinesViral Vaccines

Identifiers

PMID33306990
PMCPMC7832220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.